Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$32.28 - $41.5 $6,778 - $8,715
-210 Reduced 6.47%
3,035 $104,000
Q4 2023

Feb 14, 2024

SELL
$15.08 - $38.61 $3,845 - $9,845
-255 Reduced 7.29%
3,245 $119,000
Q3 2023

Nov 14, 2023

BUY
$18.62 - $26.57 $5,772 - $8,236
310 Added 9.72%
3,500 $70,000
Q1 2023

May 15, 2023

SELL
$14.6 - $30.9 $4,219 - $8,930
-289 Reduced 8.31%
3,190 $48,000
Q4 2022

Jun 14, 2023

BUY
$21.92 - $39.37 $6,334 - $11,377
289 Added 9.06%
3,479 $82.8 Million
Q3 2022

Jun 14, 2023

BUY
$33.44 - $56.56 $9,664 - $16,345
289 Added 9.06%
3,479 $123 Million
Q2 2022

Jun 20, 2023

BUY
$26.2 - $54.0 $7,571 - $15,606
289 Added 9.06%
3,479 $121,000
Q1 2022

Jun 20, 2023

BUY
$38.58 - $83.27 $11,149 - $24,065
289 Added 9.06%
3,479 $171,000
Q1 2022

Mar 30, 2023

SELL
$38.58 - $83.27 $347,567 - $750,179
-9,009 Reduced 72.14%
3,479 $171,000
Q1 2022

May 12, 2022

SELL
$38.58 - $83.27 $347,567 - $750,179
-9,009 Reduced 72.14%
3,479 $172,000
Q4 2021

Jun 21, 2023

BUY
$75.47 - $135.88 $701,720 - $1.26 Million
9,298 Added 291.47%
12,488 $966,000
Q3 2021

Jun 21, 2023

BUY
$95.64 - $131.48 $889,260 - $1.22 Million
9,298 Added 291.47%
12,488 $1.34 Million
Q3 2021

Mar 30, 2023

SELL
$95.64 - $131.48 $66,565 - $91,510
-696 Reduced 5.28%
12,488 $1.34 Million
Q3 2021

Nov 15, 2021

SELL
$95.64 - $131.48 $66,565 - $91,510
-696 Reduced 5.28%
12,488 $1.34 Million
Q2 2021

Jun 21, 2023

BUY
$88.13 - $142.06 $880,771 - $1.42 Million
9,994 Added 313.29%
13,184 $1.76 Million
Q2 2021

Mar 30, 2023

BUY
$88.13 - $142.06 $59,311 - $95,606
673 Added 5.38%
13,184 $1.76 Million
Q2 2021

Aug 16, 2021

BUY
$88.13 - $142.06 $1.16 Million - $1.87 Million
13,171 Added 101315.38%
13,184 $1.76 Million
Q1 2021

Jun 26, 2023

BUY
$105.48 - $207.97 $983,179 - $1.94 Million
9,321 Added 292.19%
12,511 $1.55 Billion
Q1 2021

Mar 30, 2023

BUY
$105.48 - $207.97 $340,383 - $671,119
3,227 Added 34.76%
12,511 $1.55 Million
Q1 2021

May 14, 2021

SELL
$105.48 - $207.97 $977,905 - $1.93 Million
-9,271 Reduced 99.86%
13 $1.55 Million
Q4 2020

Jun 22, 2023

BUY
$76.64 - $167.89 $467,044 - $1.02 Million
6,094 Added 191.03%
9,284 $1.31 Million
Q3 2020

Jun 26, 2023

BUY
$45.46 - $78.79 $277,033 - $480,146
6,094 Added 191.03%
9,284 $705,000
Q2 2020

Jun 26, 2023

BUY
$26.4 - $45.3 $160,881 - $276,058
6,094 Added 191.03%
9,284 $420,000
Q2 2020

Mar 30, 2023

BUY
$26.4 - $45.3 $49,473 - $84,892
1,874 Added 25.29%
9,284 $420,000
Q2 2020

Aug 14, 2020

BUY
$26.4 - $45.3 $49,473 - $84,892
1,874 Added 25.29%
9,284 $421,000
Q1 2020

Jul 12, 2023

BUY
$19.71 - $35.15 $86,684 - $154,589
4,398 Added 137.87%
7,588 $232,000
Q4 2019

Jul 12, 2023

BUY
$21.0 - $26.48 $88,620 - $111,745
4,220 Added 132.29%
7,410 $155,000
Q3 2019

Jul 12, 2023

BUY
$23.72 - $33.99 $100,098 - $143,437
4,220 Added 132.29%
7,410 $176,000
Q3 2019

Mar 30, 2023

BUY
$23.72 - $33.99 $93,243 - $133,614
3,931 Added 112.99%
7,410 $176,000
Q3 2019

Nov 14, 2019

BUY
$23.72 - $33.99 $175,765 - $251,865
7,410 New
7,410 $177,000
Q2 2019

Jul 12, 2023

SELL
$21.74 - $33.2 $34,218 - $52,256
-1,574 Reduced 49.34%
1,616 $46.9 Million

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.38B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.